Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast and intranasal budesonide for mild to moderate pediatric obstructive sleep apnea-hypopnea syndrome
ChiCTR-TRC-12002963Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of montelukast and budesonide in obstructive sleep apnea hypopnea syndrome (OSAHS) (3 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Overnight polysomnography parameters and Urinary leukotriene E4 level. Started Jan 2012; status: completed.
02
Drugs
montelukastbudesonide
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR-TRC-12002963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002963.